Initial public offering of M&E Biotech A/S (DK) — DKK 375 million

Carnegie acted as lead manager in the initial public offering and the new share issue of DKK 375 million in M&E Biotech A/S on Copenhagen Stock Exchange. M&E Biotech A/S is a Danish biotechnology company focusing on therapeutic vaccines.May, 2000.